We found that METTL1 highly expressed in high risk NBL based on the Children’s Oncology Group (COG), advanced NBL according to the International Neuroblastoma Staging System (INSS), and NBL with MYCN amplification (Fig. 1A). This evidence concerns the gene MYCN and neuroblastoma.